Overview
Hiroko Watanabe practices practicing medicine in Tsukuba, Japan.
Ms. Watanabe is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Lung Metastases, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Dyskeratosis Congenita.
She is actively involved in clinical research, co-authoring 50 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroko Watanabe
Is Hiroko Watanabe a top-rated expert for Lung Metastases?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroko Watanabe is classified as an Advanced expert for Lung Metastases, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroko Watanabe participate in research or clinical trials?
Yes. Hiroko Watanabe has published 50 articles and abstracts on conditions like Lung Metastases. You can view a list of Hiroko Watanabe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung MetastasesMs. Watanabe isAdvanced. Learn about Lung Metastases.
- Experienced
- AgranulocytosisMs. Watanabe isExperienced. Learn about Agranulocytosis.
- COVID-19Ms. Watanabe isExperienced. Learn about COVID-19.
- Dyskeratosis CongenitaMs. Watanabe isExperienced. Learn about Dyskeratosis Congenita.
- Febrile NeutropeniaMs. Watanabe isExperienced. Learn about Febrile Neutropenia.
- Lung AdenocarcinomaMs. Watanabe isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerMs. Watanabe isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Watanabe isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Severe Acute Respiratory Syndrome (SARS)Ms. Watanabe isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Small Cell Lung Cancer (SCLC)Ms. Watanabe isExperienced. Learn about Small Cell Lung Cancer (SCLC).